IL11 and breast cancer: Reduced pSTAT3 levels were also observed in the estrogen receptor (ER)‐negative breast cancer cell line, MDA‐MB‐231, confirming the ER independence of the bazedoxifene effect on IL11/gp130 signaling (Fig 3A).